Passkey Therapeutics Raises $20 Million to Advance a New Class of Multifunctional Therapeutics with Proprietary Platform Targeting Rare Combinations of Proteins
October 22, 2024 06:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Passkey Therapeutics, the pioneer of Synergistic Multifunctional Therapeutics (SMThs), announced today that it has emerged from stealth with $20 million in seed funding led by…